ChordNews
← All news

MannKind expects $1 billion in revenue from its United Therapeutics deal over 2027-2030 and targets Q4 profitability

By ChordNews · First written (updated )

Comments 0

Summary

MannKind anticipates about $1 billion in revenue from its deal with United Therapeutics over 2027 to 2030, and it is targeting profitability in the fourth quarter. This summary is based only on the headline of one Seeking Alpha breaking news item, so the drivers of the deal and any further terms are not available from the articles provided.

This continues an earlier story: Disco raises FY 2026 revenue guidance to $176.1M-$178.1M and targets Q4 adjusted EBITDA of up to $1.5M

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that MannKind anticipates $1 billion in revenue from the United Therapeutics deal from 2027 to 2030 as it targets Q4 profitability.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews